Federal Register of Legislation - Australian Government

Primary content

Determinations/Health as made
This instrument amends the National Health (Immunisation Program — Designated Vaccines) Determination 2014 (No. 1) to add VaxiGrip Tetra to the list of designated vaccines for the prevention of influenza and the circumstances, including the specified population of patients to which they may be provided, and extend the listing of Engerix-B (adult formulation) for use in adolescents and adults in the list of designated vaccines until either the shortage of H-B-Vax II (adult formulation) has been resolved, or 31 December 2020, whichever occurs first.
Administered by: Health
Registered 06 Nov 2019
Tabling HistoryDate
Tabled Senate11-Nov-2019
Table of contents.

Commonwealth Coat of Arms of Australia

 

National Health (Immunisation Program – Designated Vaccines) Amendment Determination (No.2) 2019

I, Hope Peisley, make the following Determination.

Dated   5 November 2019                                          

Ms Hope Peisley

Acting Assistant Secretary
Office of Health Protection
Chief Medical Officer Group
Department of Health

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

National Health (Immunisation Program – Designated Vaccines) Determination 2014 (No.1)      2

 

 


1  Name

                   This instrument is the National Health (Immunisation Program – Designated Vaccines) Amendment Determination (No.2) 2019.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

On the day after this instrument is registered.

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 9B(2) and 9B(5) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

National Health (Immunisation Program – Designated Vaccines) Determination 2014 (No.1)

1  After Subsection 7(8A)

Insert:

(8B)  For items 207F of Schedule 1, a designated vaccine mentioned in this

    item may be provided to:

(a)    a person who is at least 65 years; or

(b)    an Aboriginal or Torres Strait Islander person who is at least 6 months; or

(c)    a child who is at least 6 months old but less than 5 years old;

(d)    a person who is at least 6 months who:

(i)     has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or

(ii)    has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or

(iii)   has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or

(iv)   has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or

(v)    has impaired immunity, including HIV infection; or

(vi)  is less than 11 years and is receiving long term aspirin therapy; or

(e)    a woman who is pregnant.

 

2  Part 2 of Schedule 1 (table item 202A, column headed “Vaccine and the circumstances in which vaccine may be provided”, subparagraph (iii) under subheading “Circumstances”)

Omit “2019”, substitute “2020”.

 

 

 

 

 

3  Part 2 of Schedule 1 (after table item 207E)

Insert:  

 

207F

 

Vaccine

Influenza

 

Circumstances

Vaccine may be provided in the circumstances set out in subsection 7(8B)

 

VaxiGrip Tetra

Injection (0.5mL)

 

For children older than 6 months but less than 9 years, 2 doses at least 1month apart for the first vaccination and 1 dose per calendar year after that. For persons 9 years and above, 1 dose per calendar year.